Sulfametomidine
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Routes of administration | Oral |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | 27 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H14N4O3S |
| Molar mass | 294.331 g/mol |
| 3D model (JSmol) | |
| |
| |
| Template:Xmark | |
|
WikiDoc Resources for Sulfametomidine |
|
Articles |
|---|
|
Most recent articles on Sulfametomidine Most cited articles on Sulfametomidine |
|
Media |
|
Powerpoint slides on Sulfametomidine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Sulfametomidine at Clinical Trials.gov Trial results on Sulfametomidine Clinical Trials on Sulfametomidine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Sulfametomidine NICE Guidance on Sulfametomidine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Sulfametomidine Discussion groups on Sulfametomidine Patient Handouts on Sulfametomidine Directions to Hospitals Treating Sulfametomidine Risk calculators and risk factors for Sulfametomidine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Sulfametomidine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Sulfametomidine (or sulfamethomidine) is a sulfonamide antibacterial.
- Articles with short description
- Articles with changed CASNo identifier
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Sulfonamide antibiotics
- Pyrimidines
- Phenol ethers
- Drug
